This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Frost & Sullivan: Improved Safety Regulations And Heightened Foreign Competition To Positively Impact Chinese Market

MOUNTAIN VIEW, Calif., Feb. 18, 2013 /PRNewswire/ -- Widespread fears of terrorism and disease in the early 2000s caused a boom in the respiratory protection market leading to a surge in demand and funding. However, as the occurrence of such events has decreased, demand has leveled off. Improved safety regulations and enforcement efforts by Chinese government agencies are expected to offset this reduction in demand.

Frost & Sullivan's Chemicals, Materials & Food practice ( www.frost.materials.com) finds that the respiratory protection market earned revenue of $405.3 million in 2011 and estimates this to reach $610.4 million in 2016.

Click here to view the Strategic Analysis of the Chinese Respiratory Protection Market video and gain access to the online community- http://bit.ly/12bNP4d.

If you are interested in more information on this research, please send an email to Zhenhua Chen, Corporate Communications, at zhenhua.chen@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Established Chinese companies normally do not sell high-end respirators, rather, tend to participate in the low-end segments that require less technology, such as disposable or non-disposable respirators. As a result, low-end segments are highly saturated with several small competitors. These companies usually do not have strong financial portfolios and struggle to survive due to meager profit margins.

Participation by these companies in product research and development is minimal, which has hindered the development of the Chinese respiratory protection market. Additionally, some foreign manufacturers do not feature their full line of products in China, as they do not believe that the demand is high enough for expensive products. However, certain companies such as Scott Health and MSA have started to offer some of their high-end products in the Chinese market.

"Previous quality control standards in China were inadequate, thus increasing the transaction costs that end users incurred when selecting and testing respiratory protection," said Frost & Sullivan Research Analyst Roland Heinze. "As a result, inexpensive products dominated the market and lowered the quality of respirators in China relative to that of Europe and the U.S."

Over the past ten years, Chinese regulatory agencies have increased their efforts to develop improved standards for respiratory protection. Standards which are over five years old have been revised, along with new ones created, keeping in mind the technical requirements and testing methods under American, European, and International Safety Organization (ISO) standards. Competition under new policy is expected to encourage suppliers to adhere to higher quality control standards in order to remain competitive in the market. These factors will lower transaction costs for end users and increase the likelihood that the correct type of respiratory protection is used in suggested end applications.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs